Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lessons From The First Biosimilar MAb Launch In Europe

Oct 20 2014

• By Brenda Sandburg

Related Content

Biosimilar <em>Remicade</em> Will Pit Rising Cost Pressures Against Prescriber Caution

May 15 2013

Teva’s G-CSF Product Clears FDA, Leaving Appeal Of Biosimilar Pathway Uncertain

Sep 03 2012

Korea's Celltrion In Deal With U.S.-based Hospira For Biogeneric Sales; M&A Hinted At

Oct 12 2009

Related Companies

Hospira, Inc.

Celltrion, Inc.

Johnson & Johnson

Egis Pharmaceuticals PLC

Merck & Co., Inc.

Novartis AG

Pfizer Inc.

Novartis AG

Amgen, Inc.

Johnson & Johnson

Teva Pharmaceutical Industries Ltd.

Allergan plc

AbbVie Inc.

Viatris Inc.

Biocon, Ltd.

Roche Holding AG

Samsung Bioepis Co., Ltd.

Lonza Group AG

Additional Topics

Launches Clinical Trials BioPharmaceutical

More from In Vivo Archive

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window